News about "Eugia Pharma Specialities"

US FDA Classifies Aurobindo Pharma's Eugia Unit-III Inspection as Official Action Indicated

US FDA Classifies Aurobindo Pharma's Eugia Unit-III Inspection as Official Action Indicated

Aurobindo Pharma said the US FDA has classified its inspection of Eugia Unit-III in Telangana as Official Action Indicated, while reaffirming its commitment to maintaining global quality manufacturing standards.

Eugia Pharma Specialities | 16/06/2026 | By News Bureau

Eugia Pharma Gets FDA Approval for Pazopanib Tablets

Eugia Pharma Gets FDA Approval for Pazopanib Tablets

Aurobindo Pharma has announced that its wholly owned subsidiary company, Eugia Pharma Specialities, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Pazopanib Tablets, 200 mg.

Eugia Pharma Specialities | 06/12/2024 | By Aishwarya 345

Aurobindo's subsidiary Eugia Pharma Specialities receives final approval from US FDA

Aurobindo's subsidiary Eugia Pharma Specialities receives final approval from US FDA

Aurobindo's subsidiary Eugia Pharma Specialities receives final approval from US FDA to manufacture, market cancer drug Lenalidomide caps

Eugia Pharma Specialities | 11/03/2023 | By Sudeep Soparkar 1634

Aurobindo Pharma's arm Eugia Pharma Specialities bags

Aurobindo Pharma's arm Eugia Pharma Specialities bags

This is a partnership product from TTY Biopharm Company and will be manufactured at the Taiwan facility

Eugia Pharma Specialities | 18/11/2022 | By Sudeep Soparkar 1197


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members